CCL2 and fragile X syndrome: Zafarullah et al. revealed decreased levels of the chemokines Eotaxin, MCP-1, and RANTES in both the Fragile X syndrome with autism spectrum disorder (FXS + ASD) and Fragile X syndrome without autism (FXS) groups compared to the controls.